We are looking for new microbiome-based solutions, grounded in the latest advances in microbiome science, to power the next generation of biotic products—including probiotics, prebiotics, and postbiotics—targeting the following health spaces: digestive wellness, immunity, allergy prevention and relief, metabolic health, cardiovascular health, energy and vitality, brain and cognitive health, stress relief, joint health, women’s health, and skin health.​

We are particularly interested in:​

• New probiotic strains isolated from the human microbiome, especially lactic acid bacteria with specific metabolic functions;​
• Prebiotics and postbiotics with fully characterized compositions;​
• Proprietary ingredients with preclinical and/or clinical evidence of health benefits.

Our understanding of the microbiome’s role in human health has grown rapidly over the last decade, thanks to advances in omics technologies that allow detailed analysis of microbial ecosystems in large populations and specific diseases. These insights create new opportunities to develop biotic solutions that target microbiome functions more precisely. This includes discovering new probiotics from the human gut or vaginal microbiome, improving functional screening methods for traditional lactic acid bacteria, designing prebiotics with more targeted effects and lower required doses, and exploring new postbiotics based on microbial metabolites. Together, these advances are expanding microbiome-based strategies to improve not only digestive health but also metabolic, immune, liver, brain, skin, and vaginal health.

Must-have Requirements.

• Proprietary ingredients with unique functional benefits​
• Robust scientific validation of health effects supported by comprehensive preclinical studies and/or well-designed clinical trials

Preferred Requirements. ​

• Targeted health benefits: digestive health, immune support, metabolic health, cardiovascular health, brain and cognitive function, energy and vitality, joint health, women’s health, skin health (systemic, not topical), allergy relief, and stress management​
• Authorized ingredients in the EU, US, and other regions (e.g., Brazil, Mexico, Vietnam, China), or feasibility assessment for registration in these regions​
• Targeted formats : capsules, tablets, sticks, nasal sprays or other innovative formats

Approaches​ not of interest.

• GMO

Target Group​.

Adults and children, no specific health conditions​

Geographies​.

Global